Safety and effectiveness of mycophenolate mofetil in interstitial lung diseases: insights from a machine learning radiographic model

T Karampitsakos, C Kalogeropoulou, V Tzilas… - Respiration, 2022 - karger.com
Introduction: Treatment of interstitial lung diseases (ILDs) other than idiopathic pulmonary
fibrosis (IPF) often includes systemic corticosteroids. Use of steroid-sparing agents is …
被引用次数：8 相关文章

Safety and Effectiveness of Mycophenolate Mofetil in Interstitial Lung Diseases: Insights from a Machine Learning Radiographic Model

T Karampitsakos, C Kalogeropoulou… - … review of thoracic …, 2022 - pubmed.ncbi.nlm.nih.gov
Introduction Treatment of interstitial lung diseases (ILDs) other than idiopathic pulmonary
fibrosis (IPF) often includes systemic corticosteroids. Use of steroid-sparing agents is …

Safety and Effectiveness of Mycophenolate Mofetil in Interstitial Lung Diseases: Insights from a Machine Learning Radiographic Model.

T Karampitsakos, C Kalogeropoulou, V Tzilas… - …, 2022 - search.ebscohost.com
Introduction: Treatment of interstitial lung diseases (ILDs) other than idiopathic pulmonary
fibrosis (IPF) often includes systemic corticosteroids. Use of steroid-sparing agents is …

Safety and Effectiveness of Mycophenolate Mofetil in Interstitial Lung Diseases: Insights from a Machine Learning Radiographic Model.

T Karampitsakos, C Kalogeropoulou… - … Review of Thoracic …, 2021 - europepmc.org
Methods Functional indices and high-resolution computed tomography (HRCT) patterns of
patients with non-IPF ILDs receiving mycophenolate mofetil (MMF) with a minimum follow-up …

Safety and Effectiveness of Mycophenolate Mofetil in Interstitial Lung Diseases: Insights from a Machine Learning Radiographic Model

T Karampitsakos, C Kalogeropoulou, V Tzilas… - Respiration, 2022 - karger.com
Introduction: Treatment of interstitial lung diseases (ILDs) other than idiopathic pulmonary
fibrosis (IPF) often includes systemic corticosteroids. Use of steroid-sparing agents is …